Showing results (391-400 of 403) with videos related to

Sort By:
Pageof 41
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 2009
Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalisWalter Francesconi, Fulvia Berton, Vez Repunte-Canonigo, et al.
ACS Chemical Neuroscience|September 1, 2021
Discovery of Highly Potent Adenosine A<sub>1</sub> Receptor Agonists: Targeting Positron Emission Tomography ProbesMin Guo, Abolghasem Bakhoda, Zhan-Guo Gao, et al.
Journal of Medicinal Chemistry|July 13, 2007
Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan seriesAnne-Cécile Hiebel, Yong Sok Lee, Edward Bilsky, et al.
Toxicology|April 22, 2008
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonistThomas L Horn, J Brooks Harder, William D Johnson, et al.
Behavioural Brain Research|September 9, 2020
Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexoneAndrew J Kwilasz, Laurel S Todd, Julissa C Duran-Malle, et al.
Frontiers in Neuroscience|September 10, 2025
Serotonin 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> receptors differentially modulate the acquisition and expression of voluntary alcohol drinking in male miceSandy C Simões, Livia N Amorim, Yasmim A Serra, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2016
Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activationPeter M Grace, Keith A Strand, Erika L Galer, et al.
Brain, Behavior, and Immunity|December 28, 2020
Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related painAndrew J Kwilasz, Suzanne M Green Fulgham, Julissa Chante Duran-Malle, et al.
Brain, Behavior, and Immunity|August 15, 2009
Evidence that opioids may have toll-like receptor 4 and MD-2 effectsMark R Hutchinson, Yingning Zhang, Mitesh Shridhar, et al.
Psychopharmacology|March 7, 2022
Role of 5-HT<sub>2A</sub> receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male miceYasmim A Serra, Thaísa Barros-Santos, Alexia Anjos-Santos, et al.
Pageof 41